symbol,statement_type,period_end,line_item,value
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,-114542000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-35632000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,End Cash Position,1416000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,1374000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,42000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,128648000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,1000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-59142000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,187789000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,410289000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,-222500000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-49696000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,-15699000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Net Intangibles Purchase And Sale,
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-33997000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,1635000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-35632000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,-78910000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cfo,-153000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,66392000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,17531000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,3576000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Change In Payable,-8175000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,37649000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,18534000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,59142000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,-721000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,66892000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Depreciation,66892000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,-1221000.0
KREBSBIO.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,-269240000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,-49624000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-73273000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,End Cash Position,1374000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,2000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,858000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,514000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,55032000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-46894000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,0.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,101926000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,-609000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,102535000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-78167000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,-4894000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Net Intangibles Purchase And Sale,
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-73273000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,0.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-73273000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,23649000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cfo,0.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,102095000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,93010000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,-33517000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Change In Payable,36894000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,21492000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,-13782000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,46894000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,4280000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,67663000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,1838000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Depreciation,67663000.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,0.0
KREBSBIO.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,-197284000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,-355836000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-108704000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,End Cash Position,858000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,1000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,1006000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,-149000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,373433000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-29732000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,0.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,403165000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,403165000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-126450000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,-17746000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Net Intangibles Purchase And Sale,
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-108704000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,-247132000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cfo,
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-98383000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,-64303000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,51527000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Change In Payable,-226258000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,136170000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,3513000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,29732000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,2854000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,65585000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,1839000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Depreciation,63746000.0
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,
KREBSBIO.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,-246919000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,-407363000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-235201000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,End Cash Position,1006000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,7107000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,-6101000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,395056000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,1000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-53910000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,125130000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,323835000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,323835000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-228995000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,6206000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Net Intangibles Purchase And Sale,
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-235201000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,-172162000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cfo,
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,158996000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,130703000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,-44331000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Change In Payable,171297000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-89622000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-5767000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,53910000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,-2765000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,62966000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,6386000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Depreciation,56580000.0
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,
KREBSBIO.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,-445268000.0
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,104489000.0
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Net Intangibles Purchase And Sale,0.0
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cfo,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,2602000.0
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Depreciation,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
KREBSBIO.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
